355 related articles for article (PubMed ID: 33424828)
1. Acquired Hemophilia A in IgG4-Related Disease: Case Report, Immunopathogenic Study, and Review of the Literature.
Sanges S; Jeanpierre E; Lopez B; Russick J; Delignat S; Carpentier B; Dubois R; Dubucquoi S; Guerrier T; Hachulla É; Hatron PY; Paris C; Susen S; Launay D; Lacroix-Desmazes S; Terriou L
Front Immunol; 2020; 11():558811. PubMed ID: 33424828
[TBL] [Abstract][Full Text] [Related]
2. First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin.
Takeyama M; Nogami K; Kajimoto T; Ogiwara K; Matsumoto T; Shima M
Int J Hematol; 2018 Jan; 107(1):112-116. PubMed ID: 28597369
[TBL] [Abstract][Full Text] [Related]
3. Acquired hemophilia A associated with Epstein-Barr-virus-associated T/natural killer-cell lymphoproliferative disease: A case report.
Yamamoto M; Shindo M; Sumi C; Igarashi S; Saito T; Tsukada N; Toki Y; Hatayama M; Inamura J; Sato K; Mizukami Y; Torimoto Y; Okumura T
Medicine (Baltimore); 2021 Apr; 100(16):e25518. PubMed ID: 33879690
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.
Montalvão SA; Tucunduva AC; Siqueira LH; Sambo AL; Medina SS; Ozelo MC
Haemophilia; 2015 Sep; 21(5):686-92. PubMed ID: 25708525
[TBL] [Abstract][Full Text] [Related]
5. Acquired hemophilia A associated with autoimmune pancreatitis with serum IgG4 elevation.
Narazaki T; Haji S; Nakashima Y; Tsukamoto Y; Tsuda M; Takamatsu A; Ohno H; Matsushima T; Matsumoto T; Nogami K; Shima M; Shiratsuchi M; Ogawa Y
Int J Hematol; 2018 Sep; 108(3):335-338. PubMed ID: 29582334
[TBL] [Abstract][Full Text] [Related]
6. The IgG autoimmune response in postpartum acquired hemophilia A targets mainly the A1a1 domain of FVIII.
Lapalud P; Ali T; Cayzac C; Mathieu-Dupas E; Levesque H; Pfeiffer C; Balicchi J; Gruel Y; Borg JY; Schved JF; Granier C; Lavigne-Lissalde G
J Thromb Haemost; 2012 Sep; 10(9):1814-22. PubMed ID: 22784315
[TBL] [Abstract][Full Text] [Related]
7. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
Wootla B; Dasgupta S; Dimitrov JD; Bayry J; Lévesque H; Borg JY; Borel-Derlon A; Rao DN; Friboulet A; Kaveri SV; Lacroix-Desmazes S
J Immunol; 2008 Jun; 180(11):7714-20. PubMed ID: 18490775
[TBL] [Abstract][Full Text] [Related]
8. Predictive significance of anti-FVIII immunoglobulin patterns on bleeding phenotype and outcomes in acquired hemophilia A: Results from the Quebec Reference Center for Inhibitors.
Bonnefoy A; Merlen C; Dubé E; Claus-Desbonnet H; Rivard GE; St-Louis J
J Thromb Haemost; 2021 Dec; 19(12):2947-2956. PubMed ID: 34455699
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.
Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A
J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of anti-factor VIII IgG ELISA in acquired hemophilia A follow-up.
Chansavang A; Philippe A; Bozinovic I; Ben Hadj Ali K; Smadja D; Helley D; Darnige L; Mauge L
Ann Hematol; 2022 Nov; 101(11):2453-2460. PubMed ID: 36125542
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.
Boylan B; Rice AS; Dunn AL; Tarantino MD; Brettler DB; Barrett JC; Miller CH; ;
J Thromb Haemost; 2015 Jan; 13(1):47-53. PubMed ID: 25354263
[TBL] [Abstract][Full Text] [Related]
12. Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder.
Sakurai Y; Takeda T
J Immunol Res; 2014; 2014():320674. PubMed ID: 24741588
[TBL] [Abstract][Full Text] [Related]
13. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
[TBL] [Abstract][Full Text] [Related]
14. Rapid acquisition of immunologic tolerance to factor VIII and disappearance of anti-factor VIII IgG4 after prophylactic therapy in a hemophilia A patient with high-titer factor VIII inhibitor.
Moorehead PC; Thibeault L; Tuttle A; Grabell J; Dwyre L; Silva M; James P; Lillicrap D
J Pediatr Hematol Oncol; 2015 May; 37(4):e220-2. PubMed ID: 25411864
[TBL] [Abstract][Full Text] [Related]
15. Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.
Whelan SF; Hofbauer CJ; Horling FM; Allacher P; Wolfsegger MJ; Oldenburg J; Male C; Windyga J; Tiede A; Schwarz HP; Scheiflinger F; Reipert BM
Blood; 2013 Feb; 121(6):1039-48. PubMed ID: 23243272
[TBL] [Abstract][Full Text] [Related]
16. Acquired hemophilia: a case report and review of the literature.
Mulliez SM; Vantilborgh A; Devreese KM
Int J Lab Hematol; 2014 Jun; 36(3):398-407. PubMed ID: 24750687
[TBL] [Abstract][Full Text] [Related]
17. IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A.
van Helden PM; van den Berg HM; Gouw SC; Kaijen PH; Zuurveld MG; Mauser-Bunschoten EP; Aalberse RC; Vidarsson G; Voorberg J
Br J Haematol; 2008 Aug; 142(4):644-52. PubMed ID: 18510679
[TBL] [Abstract][Full Text] [Related]
18. [Identification of IgG subclass and FVIII binding epitope of an acquired FVIII inhibitor in a bullous pemphigoid patient].
Zuo WL; Zhang GS; Qing ZJ; Xu YX; Qin LX; Xu M
Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):593-7. PubMed ID: 17278424
[TBL] [Abstract][Full Text] [Related]
19. Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients.
Reding MT; Lei S; Lei H; Green D; Gill J; Conti-Fine BM
Thromb Haemost; 2002 Oct; 88(4):568-75. PubMed ID: 12362225
[TBL] [Abstract][Full Text] [Related]
20. The factor VIII:C/VWF:Ag ratio as a useful tool to predict relapse in patients with acquired haemophilia A: A retrospective cohort study.
Trossaert M; Graveleau J; Thiercelin-Legrand MF; Sigaud M; Guerrero F; Neel A; Fouassier M; Sailler L; Chauveau D; Ternisien C; Huart A; Gillet B; Hamidou M; Bene MC; Voisin S
Haemophilia; 2019 May; 25(3):527-534. PubMed ID: 31050100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
